These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 37920447)

  • 1. Molecular pathogenesis of
    Jury B; Fleming C; Huston WM; Luu LDW
    Front Cell Infect Microbiol; 2023; 13():1281823. PubMed ID: 37920447
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control.
    Dean D; Kandel RP; Adhikari HK; Hessel T
    PLoS Med; 2008 Jan; 5(1):e14. PubMed ID: 18177205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity.
    Byrne GI
    J Infect Dis; 2010 Jun; 201 Suppl 2(Suppl 2):S126-33. PubMed ID: 20470049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic features beyond Chlamydia trachomatis phenotypes: what do we think we know?
    Nunes A; Borrego MJ; Gomes JP
    Infect Genet Evol; 2013 Jun; 16():392-400. PubMed ID: 23523596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in genetic manipulation of
    Wan W; Li D; Li D; Jiao J
    Front Immunol; 2023; 14():1209879. PubMed ID: 37449211
    [No Abstract]   [Full Text] [Related]  

  • 6. Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis.
    Porcella SF; Carlson JH; Sturdevant DE; Sturdevant GL; Kanakabandi K; Virtaneva K; Wilder H; Whitmire WM; Song L; Caldwell HD
    Infect Immun; 2015 Feb; 83(2):534-43. PubMed ID: 25404022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains.
    Carlson JH; Porcella SF; McClarty G; Caldwell HD
    Infect Immun; 2005 Oct; 73(10):6407-18. PubMed ID: 16177312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TargeTron inactivation of plasmid-regulated Chlamydia trachomatis CT084 results in a nonlytic phenotype.
    Karanovic U; Lei L; Martens CA; Barbian K; McClarty G; Caldwell HD; Yang C
    Pathog Dis; 2023 Jan; 81():. PubMed ID: 37804183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine retinal cell line VIDO R1 and Chlamydia suis to modelize ocular chlamydiosis.
    Käser T; Cnudde T; Hamonic G; Rieder M; Pasternak JA; Lai K; Tikoo SK; Wilson HL; Meurens F
    Vet Immunol Immunopathol; 2015 Aug; 166(3-4):95-107. PubMed ID: 26103808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal Fibroblasts Drive Host Inflammatory Responses That Are Dependent on Chlamydia trachomatis Strain Type and Likely Influence Disease Outcomes.
    Jolly AL; Rau S; Chadha AK; Abdulraheem EA; Dean D
    mBio; 2019 Mar; 10(2):. PubMed ID: 30890604
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of Chlamydia trachomatis Growth During the Last Decade: A Mini-Review.
    Serradji N; Vu TH; Kim H; Panyam J; Verbeke P
    Mini Rev Med Chem; 2018; 18(16):1363-1372. PubMed ID: 29692244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infections with Chlamydia trachomatis].
    Stock I; Henrichfreise B
    Med Monatsschr Pharm; 2012 Jun; 35(6):209-22; quiz 223-4. PubMed ID: 22808665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive
    Patton MJ; Chen CY; Yang C; McCorrister S; Grant C; Westmacott G; Yuan XY; Ochoa E; Fariss R; Whitmire WM; Carlson JH; Caldwell HD; McClarty G
    mBio; 2018 Jan; 9(1):. PubMed ID: 29382731
    [No Abstract]   [Full Text] [Related]  

  • 14. Status of vaccine research and development of vaccines for Chlamydia trachomatis infection.
    Poston TB; Gottlieb SL; Darville T
    Vaccine; 2019 Nov; 37(50):7289-7294. PubMed ID: 28111145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatis.
    Massari P; Toussi DN; Tifrea DF; de la Maza LM
    Infect Immun; 2013 Jan; 81(1):303-10. PubMed ID: 23132491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
    Marks M; Bottomley C; Tome H; Pitakaka R; Butcher R; Sokana O; Kako H; Solomon AW; Mabey DC
    Sex Transm Infect; 2016 Jun; 92(4):261-5. PubMed ID: 26888658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia trachomatis genotypes A and B from urogenital specimens of patients in Spain: molecular characterization.
    Piñeiro L; Isaksson J; Zapico M; Cilla G; Herrmann B
    Clin Microbiol Infect; 2018 Aug; 24(8):910.e5-910.e8. PubMed ID: 29427803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes.
    Butcher R; Houghton J; Derrick T; Ramadhani A; Herrera B; Last AR; Massae PA; Burton MJ; Holland MJ; Roberts CH
    J Microbiol Methods; 2017 Aug; 139():95-102. PubMed ID: 28487054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia trachomatis polymorphic membrane protein D is a virulence factor involved in early host-cell interactions.
    Kari L; Southern TR; Downey CJ; Watkins HS; Randall LB; Taylor LD; Sturdevant GL; Whitmire WM; Caldwell HD
    Infect Immun; 2014 Jul; 82(7):2756-62. PubMed ID: 24733093
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Chavda VP; Pandya A; Kypreos E; Patravale V; Apostolopoulos V
    Expert Rev Vaccines; 2022 Jun; 21(6):771-781. PubMed ID: 35470769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.